MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Items 701–800 of 828
Jeon, J., Jang, S., Park, K., Kim, H., Lee, J., Hwang, T. S., Koh, J., & Kim, J. (2024) · Biogerontology · doi:10.1007/s10522-024-10167-x · Cited by 5
MicroRNAs as Novel Biomarkers in Cardiovascular Medicine
Vogel, B., Katus, H. A., & Meder, B. (2014) · Wiley eBooks · doi:10.1002/9783527672165.ch02 · Cited by 2
Self-citationDuc, H. T. (2014) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2014.03.006 · Cited by 2
The Emerging Role of Epigenetics
Wang, L. Q., Singh, K. N., Zaw, A. M., & Chow, B. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1429-2_3 · Cited by 2
MicroRNAs (miRs) in Muscle Gene Therapy
Rotini, A., Giacomazzi, G., Filippo, E. S. D., & Sampaolesi, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-03095-7_6 · Cited by 3
Non-coding RNAs in Cardiomyopathy and Heart Failure
Holvoet, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-68844-8_6 · Cited by 2
Feinberg, M. W. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.06.001 · Cited by 2
Epigenetic regulation in diabetes-associated oxidative stress and myocardial dysfunction
Yin, L., Chilian, W. M., & Dong, F. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.058 · Cited by 2
Zhao, Z., Lei, W., Miao, S., Wu, J., Yang, Z., Han, X., Li, J., Yao, M.-C., Lu, X., He, L., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.314175 · Cited by 2
“For telomere shortening, our results were supported by a Nature article showing reduced telomere length in C57BL/6 aging heart.(13) By contrast, the letter writers’ study failed to include young controls for telomere study (Figure 4 in the study by Grigorian-Shamagian et al).”
ResultKatsanos, S., & Parissis, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.10868-3 · Cited by 2
Ageing at Molecular Level: Role of MicroRNAs
Yadav, S., Sarkar, S., Pandey, A. K., & Singh, T. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_9 · Cited by 2
Han, X., Liu, K., Gao, F., Yang, M., & Wang, F. (2023) · Open Medicine · doi:10.1515/med-2023-0754 · Cited by 1
“Also, miR-34a was found to spawn in the aging heart, and miR-34a knockdown reduces the death of age-associated cardiomyocytes in vivo [20].”
BackgroundColasanti, J. J., Santeford, A. C., Lin, J. B., Terao, R., Lee, T. J., & Apte, R. S. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524037123 · Cited by 1
Szymczyk, A., Chocholska, S., Radko, K., Hus, M., & Podhorecka, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324320 · Cited by 1
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines
Corsi, A., Simone, T. D., Valentino, A., Orlandi, E., Stefani, C., Patuzzo, C., Fochi, S., Bruno, M. G., Trabetti, E., Rotondo, J. C., et al. (2025) · Non-Coding RNA · doi:10.3390/ncrna11040060 · Cited by 1
Angiotensin II, miR-34a, and AGTRAP crosstalk in arterial smooth muscle cells
Florio, M. C., Sileno, S., Jiang, L., D'Agostino, M., Syed, S. B., Monteonofrio, L., Baranzini, M., Prampolini, C., Macrì, F., Casaburo, M., et al. (2025) · GeroScience · doi:10.1007/s11357-025-02018-5 · Cited by 1
“It has been previously shown that miR-34a expression increases with aging in a variety of tissues including the heart [19, 34], brain [35], liver [36], endothelium, and spleen [37]; and our results demonstrate an age-associated increase of miR-34a expression also in the kidney.”
Orchestrating HFpEF: How Noncoding RNAs Drive Pathophysiology and Phenotypic Outcomes
Alifragki, A., Katsi, V. K., Fragkiadakis, K., Karagkounis, T., Kopidakis, N., Kallergis, E. M., Zacharis, E. A., Kampanieris, E., Simantirakis, E., Tsioufis, K. P., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411937 · Cited by 1
“Through downregulation of its target PNUTS —an anti-apoptotic regulatory gene— miR-34a enhances cardiomyocyte apoptosis via modulation of the checkpoint kinase-2 pathway and TRF2-related telomere-shortening mechanisms, processes known to reduce cellular lifespan [141,142].”
Metabolic regulation during sport events: factual interpretations and inadequate allegations
Poortmans, J. R., & Carpentier, A. (2013) · Revista Brasileira de Educação Física e Esporte · doi:10.1590/s1807-55092013005000020 · Cited by 1
Differential Expression of Long Noncoding RNA in the Rat Brain During Aging
Kour, S., & Rath, P. C. (2016) · Springer eBooks · doi:10.1007/978-981-10-2155-8_10 · Cited by 1
Noncoding RNAs in Ischemic Cardiovascular Disease and Repair Mechanisms
Landmesser, U., & Jakob, P. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-52945-5_4 · Cited by 1
Role of microRNAs in cardiovascular diseases and their therapeutic implications
Kumar, S., & Suryawanshi, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815669-8.00009-9 · Cited by 1
Age-Linked Non-Transmissible Diseases
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_6 · Cited by 1
Myocardial Cell Aging in the Elderly
Li, W., & Liu, F. (2020) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2020.09.029 · Cited by 1
“This in turn results in decreases both in myocardial contractility and in cardiac output [3-5].”
BackgroundMicroRNAs Regulating Autophagy in Neurodegeneration
Lai, Q., Kovzel, N., Konovalov, R., & Vinnikov, I. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-2830-6_11 · Cited by 1
Castaño, I. M., Raftery, R. M., Curtin, C. M., Grillari, J., Redl, H. R., & O’Brien, F. J. (2020) · Springer eBooks · doi:10.1007/978-3-319-08831-0_34 · Cited by 2
Bartenschlager, A., & Nürnberg, V. (2019) · Springer eBooks · doi:10.1007/978-3-658-25577-0_3 · Cited by 1
The Concepts of Biorhythms, Redundancy and Reserve: Impact on Cardiovascular Aging and Disease
Nikhra, V. (2019) · Open Access Journal of Gerontology & Geriatric Medicine · doi:10.19080/oajggm.2019.05.555656 · Cited by 1
“The evidence suggests that increased miR-34a expression in the aged heart contributes to cardiac aging [40].”
BackgroundHalder, E., Paul, N. C., & Banjerjee, P. K. (2024) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20240841 · Cited by 1
“(41, 42) However, further studies are needed to investigate the safety and efficacy of miRNA-34a inhibition in human clinical trials.”
BackgroundNguyen, H. D., & Kim, M.-S. (2024) · Epigenetics and human health · doi:10.1007/978-3-031-64788-8_10 · Cited by 1
Sex-specific dysregulation of cardiac-enriched microRNAs with age in Drosophila melanogaster
Varghese, L. N., Sheard, P. W., Schwenke, D. O., & Katare, R. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00134.2025 · Cited by 1
Role and regulation of microRNAs in adipose tissue during aging
Tong, X. (2018) · theses.fr (ABES) · doi:10.70675/3294afc2z9d74z4e24z9708z38c77ff0efec · Cited by 1
Sex and Gender Differences in Cardiovascular Disease
Mathews, L. M., Chandrashekar, P., Prasad, M., Miller, V. M., Sharma, K., Sedlak, T., Merz, C. N. B., & Ouyang, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.64153-4 · Cited by 1
Age- and Sex-Dependent Caveolar Gene Expression in Normoxic and Post-Ischemic Mouse HeartsPreprint
Kiessling, C. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.01.582960 · Cited by 1
Absence of mutation in miR-34a gene in a Chinese longevity population.
Wu, H., He, Y., Xu, T., & Kong, Q. (2015) · PubMed · doi:10.13918/j.issn.2095-8137.2015.2.112
“The inhibition of miR-34a regulates cardiac aging through silencing or genetic deletion in mice (Boon et al, 2013).”
BackgroundMicroRNA-34a: a new player in arterial inflammaging
(2015) · RNA & DISEASE · doi:10.14800/rd.753
“Recently miRNA-34a expression have been shown to increase with age in different tissues and organs of humans and mice ([9-11]).”
BackgroundSummary of Basic Science Activities at the European Society of Cardiology Congress in Barcelona 2014
Thum, T. (2014) · ESC Heart Failure · doi:10.1002/ehf2.12018
Harrison, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3987
Regulation of cardiac form and function: small RNAs and large hearts
Wijnen, W. J. (2015) · Data Archiving and Networked Services (DANS)
The role of miR-34 in epithelial to mesenchymal transition and metastasis of colorectal cancer
Siemens, H. (2014) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16641
Epigenetic and genetic mechanisms through which Myostatin regulates muscle wasting
Lua, G. B. J. (2016) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/65954
LIN28/let-7 Axis as a Regulator of Myocardial Ischemic Injury
Joshi, S. (2016)
Dimmeler, S., & Ozkan, J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv389
Self-citationAging of Murine Hematopoietic Stem Cells
Wojtowicz, E. E., Verovskaya, E. V., & de Haan, G. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1232-8_6
Assessment of circulating microRNA expression in patients with cardiovascular pathology
Кочетов, А. Г., Lyang, O. V., Рашитович, Г. Р., Abramov, A. A., Жиров, И. В., Skvortsov, A. A., Zaseeva, A. V., Bosykh, E. G., Masenko, V. P., & Tereshchenko, S. N. (2016) · Laboratory Service · doi:10.17116/labs20165228-31
“Подавление экспрессии микроРНК-34а приводит к снижению гипертрофии, фиброза, апоптоза стареющих клеток и улучшает восстановление миокарда в модели животных после инфаркта миокарда (ИМ) [4].”
The Critical Role of Circadian Rhythms in the Pathophysiology of Cardiovascular Disease
Alibhai, F. J. (2016) · The Atrium (University of Guelph)
THE RELEVANCE OF MICRORNAS IN VASCULAR AGING
Wong, P., & Jong, H. L. (2014) · Journal of Health and Translational Medicine · doi:10.22452/jummec.vol17no2.4
MicroRNA inhibitor screening: Searching for angiogenesis modulators in human endothelial cells
de Abreu, R. C. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Thomas, C., & Zapico, S. C. (2017) · CRC Press eBooks · doi:10.1201/9781315371382-28
Control of Cardiomyocyte Proliferation by p53/MDM2-Regulated microRNAs
Stanley-Hasnain, S. (2016) · TSpace (University of Toronto)
Barwari, T., Joshi, A., & Mayr, M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.063
OBSOLETE: Sex and Gender Differences in Cardiovascular Disease
Ouyang, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64153-3
Molecular Aspects of Right Ventricular Adaptation to Stress
Reddy, S., & Bernstein, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-67096-6_3
The role of non-coding RNA/microRNAs in cardiac disease
Reckman, Y. J., & Pinto, Y. M. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198757269.003.0031
Mechanism of Immune Response Through mRNA/miRNA Effect in Vascular Dysfunctions
Jiang, H. F., Ali, H., & Iftikhar, H. B. (2018) · Cardiology and Cardiovascular Medicine · doi:10.26502/fccm.92920045
“However, the sensitivity in the exacerbations of resistance and injury impinges the pathways of at responding the diagnostic of CVD [12, 13].”
BackgroundСтарченко, Т. Г., Koval, S. M., Yushko, K. O., Shkapo, V. L., & Miloslavsky, D. К. (2018) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2018-3-1-145-42-46
The Ishemia Reperfusion Injury Challenge
Cokkinos, D. V. (2019) · Springer eBooks · doi:10.1007/978-3-319-98186-4_6
Therapeutisches Potenzial der nicht kodierenden RNAs für die akute und chronische Myokardischämie
Rogg, E.-M., & Dimmeler, S. (2019) · Aktuelle Kardiologie · doi:10.1055/a-0861-8025 · Cited by 1
“Dabei hält PNUTS auch die Herzfunktion nach MI aufrecht, wenn es in Kardiomyozyten direkt überexprimiert wird [28].”
BackgroundInfluentialSelf-citationRegulation of mitochondrial function by Myocardin during cardiac development and disease
Mughal, W. (2019) · Mspace (University of Manitoba)
The micro RNAs in human pathology: clinical utility and translational approach
Vélez-Páez, J. L., Jaramillo, P. R. M., Montalvo-Villagómez, M., Moscoso, S. X. A., Páez, P. A. V., Montero, C. G. V., Jara, F., & Paz‐y‐Miño, C. (2020) · Bionatura · doi:10.21931/rb/2020.05.01.13
Осокина, А. В., Каретникова, В. Н., Polikutina, O. M., Gruzdeva, O. V., Solodilova, T. P., Косарева, С. Н., & Барбараш, О. Л. (2019) · Russian Medicine · doi:10.18821/0869-2106-2019-25-3-151-157
Rui, H., Li, R., Liu, L., Han, Z., Yu, H., Qin, D., Gong, X., Cao, S., Yuan, Q., Xu, F., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-107249/v1
Assessment of the therapeutic potential of anti-miR 24 and anti-miR 34 in cardiac diseases
Li, C., Li, J., Sun, X., Huang, J., & Yao, C. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i7.15
“Moreover, expression of miR-34a and anti-miR-92a promoted potential therapeutic effects on acute myocardial infarction [23,24].”
BackgroundOBSOLETE: Heart Failure in the Elderly
Parissis, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.10868-2
Taenia solium microRNAs: Potential Biomarkers and Drug Targets in Neurocysticercosis
Pérez, M. G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97305
The role of Telomeres in the development of Cardiac Hypertrophy
Booth, S. A. (2017) · FedUni ResearchOnline (Federation University Australia)
Gomez-Cid, L., Moro-López, M., Nava, A., Fernandez, A. I., Fernández‐Santos, M. E., Atienza, F., Grigorian, L., & Fernández‐Avilés, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab724.3317
Could miR34a be as a Potential Biomarker for Doxorubicin Induced Cardiotoxicity?Preprint
Yıldırım, E. Ç., Gedik, E., Günaydın, G., Çöteli, C., Ozer, N., Üner, A., Yüce, D., & Türker, A. (2021) · Research Square · doi:10.21203/rs.3.rs-962788/v1
[Javel's ophthalmometer, modified to corneal microscope].
VARGA, B. (1951) · PubMed
Chiao, Y. A., Dai, D., Wessells, R. J., & Rabinovitch, P. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00015-9 · Cited by 1
Castaño, I. M., Raftery, R. M., Curtin, C. M., Grillari, J., Redl, H. R., & O’Brien, F. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-37076-7_34-1 · Cited by 2
Epigenetics: Its Role in Aging, Diseases and Biological Age Estimation
Thomas, C., & Zapico, S. C. (2016) · CRC Press eBooks · doi:10.1201/9781315371382-29
Gatto, C. D. V. G. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.39.2022.tde-24052022-143144
Diagnostics and Prevention: Landscape for Technology Innovation in Precision Cardiovascular Medicine
Mauch, J., Thachil, V., & Tang, W. H. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-816861-5.00004-6
Schoger, E. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9564
Pagiatakis, C., Gornati, R., & Papait, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00004-9
Paul, N. C., Banjerjee, P. K., & Hossain, M. J. (2023) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20230634
The role of epigenetics in cardiovascular disease
Farina, F. M., Hall, I. F., Pagiatakis, C., Climent, M., & Elia, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-21863-7.00004-4
RNA interference-based therapies for atherosclerosis: Recent advances and future prospects
Parsamanesh, N., Poudineh, M., Siami, H., Butler, A. E., Almahmeed, W. A., & Sahebkar, A. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.009 · Cited by 3
Unlocking the dark matter: noncoding RNAs and RNA modifications in cardiac aging
Kang, J., Rhee, J., Wang, C., Yang, Y., Li, G., & Li, H. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00532.2023 · Cited by 1
Long noncoding RNAs and miRNAs
Duttaroy, A. K., & Mallick, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99570-2.00013-8
DNA‐Based Nanocarriers to Sequester Altered microRNAs in Cardiac Dysfunction
Postigo, A., Bellido, N. H., Barat, M. S., García‐Mendívil, L., Pueyo, E., del Barrio, J., Hernández‐Ainsa, S., & Ordovás, L. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400247
Specific functions and therapeutic applications of microRNAs in aging and age-related diseases
Kim, D., Lee, N., & Lee, H. (2024) · Journal of Applied Biological Chemistry · doi:10.3839/jabc.2024.062
Li, Q., Ping, X., Yu, Z., Yi, Q., Tang, C., Wang, X., & Zheng, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.25.640161
Huang, P., Fu, J. F., Hu, J., Lei, Y., Wu, T., & Liu, J. (2025) · Medicine · doi:10.1097/md.0000000000041972
“The search terms “mouse,” “aging,” “heart” and “mRNA” provided the datasets, GSE43556 [9] and GSE8146, [10] which were found to meet the conditions.”
Li, Q., Ping, X., Yu, Z., Yi, Q., Tang, C., Wang, X., & Zheng, L. (2025) · eLife · doi:10.7554/elife.106502
Li, Q., Ping, X., Yu, Z., Yi, Q., Tang, C., Wang, X., & Zheng, L. (2025) · eLife · doi:10.7554/elife.106502.1
RNA-Based Molecular Applications as Tool Compounds in Diagnostic and Clinical Settings
Singh, S., Gupta, K., Mishra, S., & Sharma, N. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-3456-9_8
Aksoy, Z. B., Aydos, D., Kocakaya, E., Uyar, R., Turan, B., & Bitirim, C. V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.12.653385
Das Herz des Alters – das Altern des Herzens
Alber, H. F. (2025) · Springer eBooks · doi:10.1007/978-3-662-70207-9_4
Echocardiography Dedicated to Small Animal Models (Rodents) in Non-Ischemic CardiomyopathiesPreprint
Sapalo, A. T., Neto, P. D. O., & Romano, M. M. D. (2025) · Preprints.org · doi:10.20944/preprints202505.1456.v1
Precision health and medicine in cardio-oncology
Lee, J. G., & Sun, L. Y. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29829-5.00022-0
Identification of candidate long non-coding RNAs and mRNAs associated with heart aging in mice
Kuai, Z., Li, Z., Jia, J., Chen, Y., Zhang, X., Zhang, J., Ye, Y., Gao, L., Li, L., & Hu, Y. (2025) · PeerJ · doi:10.7717/peerj.20433
“For instance, miR-34a, miR-29, and miR-199 promote cardiac aging through mechanisms involving apoptosis, fibrosis, and impaired tissue regeneration ( Boon et al., 2013 ; Lyu et al., 2018 ; Eulalio et al., 2012 ).”
Ergir, E. (2023) · reposiTUm (TU Wien) · doi:10.34726/hss.2023.50391
Pina Beltrán, B., Vidal, L. O., & Ramos-Marquès, E. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.